Mangalam Drugs & Organics Limited (BOM:532637)

India flag India · Delayed Price · Currency is INR
86.36
+0.64 (0.75%)
At close: Jul 18, 2025
0.75%
Market Cap1.41B
Revenue (ttm)3.18B
Net Income (ttm)67.21M
Shares Out15.83M
EPS (ttm)4.25
PE Ratio20.98
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,024
Average Volume8,913
Open86.00
Previous Close85.72
Day's Range84.20 - 86.70
52-Week Range65.50 - 144.65
Beta-0.06
RSI56.94
Earnings DateAug 8, 2025

About Mangalam Drugs & Organics

Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers API products, including acyclovir, amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, primaquine and piperaquine phosphate, pyrimethamine, pyronaridine tetraphosphate, ... [Read more]

Industry Pharmaceutical Preparations
Founded 1972
Employees 432
Stock Exchange Bombay Stock Exchange
Ticker Symbol 532637
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.